In conclusion, our study identified the dysregulations of NLRP3 inflammasome-related genes and their associations with the immune landscape, subtypes of patients, phenotype-related hub genes, and potential drugs of Crohn’s disease. The gene discussed is NLRP3; the disease is Crohn disease.